Skip to main content

. 1946 Jul;25(4):474–479. doi: 10.1172/JCI101730

CLINICAL USES OF 2,3—DIMERCAPTOPROPANOL (BAL). III. STUDIES ON THE TOXICITY OF BAL ON PERCUTANEOUS AND PARENTERAL ADMINISTRATION ^¹

Marion B Sulzberger ¹, Rudolf L Baer ¹, Abram Kanof ¹

PMCID: PMC435586 PMID: 16695340

474

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Longcope W. T., Luetscher J. A., Wintrobe M. M., Jäger V. CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). VII. THE TREATMENT OF ARSENICAL DERMATITIS WITH PREPARATIONS OF BAL. J Clin Invest. 1946 Jul;25(4):528–533. doi: 10.1172/JCI101734. [DOI] [PMC free article] [PubMed] [Google Scholar]
Modell W., Gold H., Cattell M. CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). IV. PHARMACOLOGIC OBSERVATIONS ON BAL BY INTRAMUSCULAR INJECTION IN MAN. J Clin Invest. 1946 Jul;25(4):480–487. doi: 10.1172/JCI101731. [DOI] [PMC free article] [PubMed] [Google Scholar]
Sulzberger M. B., Baer R. L., Kanof A. CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). V. SKIN SENSITIZATION TO BAL. J Clin Invest. 1946 Jul;25(4):488–496. doi: 10.1172/JCI101732. [DOI] [PMC free article] [PubMed] [Google Scholar]
Waters L. L., Stock C. BAL (BRITISH ANTI-LEWISITE). Science. 1945 Dec 14;102(2659):601–606. doi: 10.1126/science.102.2659.601. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES